$62.39
+2.37 (+3.95%)
Performance
1D
—
1W
—
1M
—
3M
-1.14%
6M
+15.77%
1Y
+43.00%
YTD
+1.07%
Open$60.12
Previous Close$60.02
Day High$62.39
Day Low$60.11
52W High$70.98
52W Low$29.31
Volume—
Avg Volume2.16M
Market Cap7.60B
P/E Ratio—
EPS$-6.53
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$63.59
Below
SMA 200
$49.97
Above
RSI (14)
55.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
+27.9% upside
Current
$62.39
$62.39
Target
$79.81
$79.81
$53.35
$79.81 avg
$115.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 90.28M | 92.47M | 617.31M |
| Net Income | -804,955,137 | -742,046,116 | 113.32M |
| Profit Margin | -891.6% | -847.0% | 18.4% |
| EBITDA | -742,018,944 | -722,030,110 | 314.99M |
| Free Cash Flow | — | — | 143.60M |
| Rev Growth | -2.4% | -2.4% | +3.9% |
| Debt/Equity | 0.59 | 0.59 | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |